Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

volumetric uptake values of 18-FDGal will be measured and the 18-FDGal PET/CT one month after stereotactic body radioation therapy will be compared to the baseline status in sub-volumes receiving more than 15 Gy

Outcome Time Frame:

up to 2 years

Safety Issue:

No

Authority:

Denmark: Danish Dataprotection Agency

Study ID:

210982

NCT ID:

NCT01861873

Start Date:

August 2013

Completion Date:

March 2016

Related Keywords:

• Liver Metastases
• liver function
• galactose
• 18-F-deoxy-galactose
• Neoplasm Metastasis
• Neoplasms, Second Primary
• Liver Neoplasms